Becker's Hospital Review | Healthcare News & Analysis

Author's posts

Trinity Health expands virtual nursing to 26 hospitals, 11 states

Livonia, Mich.-based Trinity Health, which has one of the largest and most robust virtual nursing programs in the U.S., has expanded the care model.

Seattle Children's racial discrimination lawsuit trial begins: 7 things to know

A civil trial has commenced to determine whether Seattle Children’s racially discriminated against the former medical director of one of its clinics, The Seattle Times reported Nov. 26.

Cleveland Clinic reverses Q3 operating loss with 1.1% margin

Cleveland Clinic reported an operating income of $43.4 million (1.1% margin) in the third quarter, reversing a $14.9 million operating loss (-0.4% margin) in the same period last year.

Controversial Alzheimer's drug trial halted

Cassava Sciences announced that the phase 3 trial of its Alzheimer’s drug, simufilam, did not meet its primary endpoints. 

Healthcare leaders urge Congress to recognize pharmacists as providers

In a Nov. 25 letter sent to congressional leaders, the Healthcare Leadership Council pressed legislators to restore pandemic-era pharmacist scopes of practice.

Sale of 2 Prospect Rhode Island hospitals approved: 7 things to know

Los Angeles-based Prospect Medical Holdings has received approval from Rhode Island Director of Health Jerry Larkin, MD, to sell two of its state hospitals to The Centurion Foundation, an Atlanta-based nonprofit.  

Physician's TikTok over Texas' patient citizenship law spurs warning from governor

Texas Gov. Greg Abbott has suggested hospitals may risk losing CMS funding if they fail to comply with an executive order requiring hospitals to inquire about patients’ citizenship status. 

OSU Wexner Medical Center, Siemens Healthineers ink $105M 'value partnership'

The Ohio State University Wexner Medical Center signed a 10-year deal with Siemens Healthineers to accelerate clinical care breakthroughs.

GLP-1s reduced risk of major cardiac event by 13%: 5 things to know

GLP-1 medications reduced the risk of major adverse cardiovascular events by 13% compared to a placebo, according to a study published Nov. 25 in The Lancet Diabetes & Endocrinology.

5 things to know about new healthcare cybersecurity bill

Four U.S. senators have introduced a new bill to fight healthcare cyberattacks.